Brooke Harrow
About Brooke Harrow
Brooke Harrow is a Senior Director of Health Economics and Outcomes Research at Deciphera Pharmaceuticals, with extensive experience in the field spanning over two decades. She has held leadership roles in various organizations, specializing in oncology and rare diseases, and has a strong background in health policy and pharmacoeconomics.
Current Role at Deciphera Pharmaceuticals
Brooke Harrow serves as the Senior Director of Health Economics and Outcomes Research at Deciphera Pharmaceuticals. She has held this position since 2021 and operates in a hybrid work environment in Waltham, Massachusetts. In her current role, she focuses on advancing health economics and outcomes research to support the company's product value propositions.
Previous Experience at TESARO
Prior to her current role, Brooke worked at TESARO as the Director of Health Economics and Outcomes Research from 2015 to 2019. During her four years at the company, she contributed to various projects aimed at enhancing the understanding of health economics in oncology.
Educational Background
Brooke Harrow earned her PhD in Economics of Health and Mental Health from The Heller School for Social Policy and Management at Brandeis University, where she studied from 1987 to 1992. She also holds a BA in Economics from Tufts University, which she completed from 1980 to 1984.
Expertise in Health Economics
Brooke specializes in health economics, particularly in oncology and rare diseases. Her expertise encompasses health policy, pharmacoeconomics, patient-reported outcomes research, global health technology assessment, and real-world data analysis. She has a proven track record in leading successful reimbursement submissions to regulatory and health technology assessment authorities across multiple countries.
Career Progression and Roles
Brooke has held various significant positions throughout her career. Before joining Deciphera Pharmaceuticals, she worked at Ipsen as Director of Global HEOR from 2019 to 2021, and at Vertex Pharmaceuticals in multiple roles, including Associate Director and Director of Health Outcomes. Her career spans over two decades, with experience in both research and leadership in health economics.